Market News

As Lifepoint Health (LPNT) Shares Declined, Stanley-Laman Group LTD Raised by $501,201 Its Position; Emerald Mutual Fund Advisers Trust Has Cut Take Two Interactive Software (TTWO) Stake by $10.57 Million; Market Value Rose

Emerald Mutual Fund Advisers Trust decreased its stake in Take Two Interactive Software (TTWO) by 44.4% based on its latest 2017Q3 regulatory filing with the SEC. Emerald Mutual Fund Advisers Trust sold 103,619 shares as the company’s stock rose 13.22% with the market. The institutional investor held 129,767 shares of the technology company at the end of 2017Q3, valued at $13.27 million, down from 233,386 at the end of the previous reported quarter. Emerald Mutual Fund Advisers Trust who had been investing in Take Two Interactive Software for a number of months, seems to be less bullish one the $13.38 billion market cap company. The stock increased 0.27% or $0.32 during the last trading session, reaching $117.3. About 1.76 million shares traded. Take-Two Interactive Software, Inc. (NASDAQ:TTWO) has risen 81.23% since January 16, 2017 and is uptrending. It has outperformed by 64.53% the S&P500.

Stanley-Laman Group Ltd increased its stake in Lifepoint Health Inc (LPNT) by 14.76% based on its latest 2017Q3 regulatory filing with the SEC. Stanley-Laman Group Ltd bought 8,793 shares as the company’s stock declined 3.05% while stock markets rallied. The institutional investor held 68,381 shares of the health care company at the end of 2017Q3, valued at $3.96 million, up from 59,588 at the end of the previous reported quarter. Stanley-Laman Group Ltd who had been investing in Lifepoint Health Inc for a number of months, seems to be bullish on the $1.96B market cap company. The stock increased 2.59% or $1.25 during the last trading session, reaching $49.6. About 744,229 shares traded or 37.99% up from the average. LifePoint Health, Inc. (NASDAQ:LPNT) has declined 5.01% since January 16, 2017 and is downtrending. It has underperformed by 21.71% the S&P500.

Among 22 analysts covering Lifepoint Hospitals (NASDAQ:LPNT), 4 have Buy rating, 3 Sell and 15 Hold. Therefore 18% are positive. Lifepoint Hospitals had 53 analyst reports since August 4, 2015 according to SRatingsIntel. The rating was maintained by Citigroup with “Buy” on Monday, June 6. The stock of LifePoint Health, Inc. (NASDAQ:LPNT) earned “Mkt Perform” rating by Avondale on Wednesday, November 9. Raymond James maintained LifePoint Health, Inc. (NASDAQ:LPNT) on Tuesday, August 2 with “Outperform” rating. The stock has “Market Perform” rating by Raymond James on Monday, October 30. As per Wednesday, January 6, the company rating was maintained by Barclays Capital. The stock of LifePoint Health, Inc. (NASDAQ:LPNT) earned “Buy” rating by Mizuho on Monday, August 3. On Friday, October 2 the stock rating was initiated by Citigroup with “Buy”. The rating was maintained by Cantor Fitzgerald with “Hold” on Monday, August 10. As per Friday, October 13, the company rating was maintained by SunTrust. RBC Capital Markets maintained the shares of LPNT in report on Tuesday, November 3 with “Outperform” rating.

Investors sentiment increased to 1.3 in 2017 Q3. Its up 0.12, from 1.18 in 2017Q2. It is positive, as 19 investors sold LPNT shares while 61 reduced holdings. 31 funds opened positions while 73 raised stakes. 40.50 million shares or 0.54% more from 40.28 million shares in 2017Q2 were reported. Voya Invest Ltd Limited Liability Company holds 11,056 shares. Rhumbline Advisers owns 67,911 shares. 31,023 are owned by Piermont Cap Management. Convergence Invest Ptnrs Lc invested in 14,001 shares or 0.11% of the stock. Pennsylvania-based Stevens Cap Ltd Partnership has invested 0.05% in LifePoint Health, Inc. (NASDAQ:LPNT). State Common Retirement Fund holds 0.01% or 84,969 shares in its portfolio. State Street Corp has 1.14 million shares for 0.01% of their portfolio. Whittier Trust holds 0.03% of its portfolio in LifePoint Health, Inc. (NASDAQ:LPNT) for 13,554 shares. First Quadrant Lp Ca holds 0.1% in LifePoint Health, Inc. (NASDAQ:LPNT) or 87,096 shares. Nationwide Fund Advsr reported 205,223 shares. 5,000 are owned by Fca Corporation Tx. Winfield Assoc accumulated 20 shares. Morgan Stanley holds 284,443 shares or 0% of its portfolio. Jefferies Ltd Liability Corp owns 0% invested in LifePoint Health, Inc. (NASDAQ:LPNT) for 4,021 shares. Ameritas Ptnrs Inc reported 0.03% in LifePoint Health, Inc. (NASDAQ:LPNT).

Stanley-Laman Group Ltd, which manages about $747.00M and $374.64M US Long portfolio, decreased its stake in Pfizer Incorporated (NYSE:PFE) by 15,108 shares to 99,176 shares, valued at $3.54M in 2017Q3, according to the filing. It also reduced its holding in Cvs Health Corp (NYSE:CVS) by 4,993 shares in the quarter, leaving it with 38,296 shares, and cut its stake in Palo Alto Networks (NYSE:PANW).

Investors sentiment decreased to 1.18 in Q3 2017. Its down 0.10, from 1.28 in 2017Q2. It worsened, as 40 investors sold TTWO shares while 124 reduced holdings. 72 funds opened positions while 122 raised stakes. 100.22 million shares or 0.81% more from 99.42 million shares in 2017Q2 were reported. River & Mercantile Asset Ltd Liability Partnership has invested 0.54% of its portfolio in Take-Two Interactive Software, Inc. (NASDAQ:TTWO). Prudential Financial Incorporated invested in 0.01% or 77,314 shares. Northern has invested 0.02% of its portfolio in Take-Two Interactive Software, Inc. (NASDAQ:TTWO). Conatus LP has invested 1.85% in Take-Two Interactive Software, Inc. (NASDAQ:TTWO). Benjamin F Edwards & holds 0.01% of its portfolio in Take-Two Interactive Software, Inc. (NASDAQ:TTWO) for 500 shares. Comerica Bancshares owns 106,553 shares. Blair William And Com Il owns 2,785 shares. Mason Street Advisors Ltd Liability Co reported 52,874 shares. Virginia Retirement Systems Et Al holds 0.02% or 19,500 shares. Utah Retirement reported 0.04% stake. Aperio Gru Ltd Liability Co accumulated 25,780 shares. Bogle Invest Mgmt Limited Partnership De, a Massachusetts-based fund reported 148,643 shares. Cornerstone Capital Mgmt Holdg Limited accumulated 192,450 shares. Tygh Cap Management invested in 1.27% or 62,070 shares. The New York-based Goldman Sachs has invested 0.02% in Take-Two Interactive Software, Inc. (NASDAQ:TTWO).

Among 19 analysts covering Take-Two Interactive Software (NASDAQ:TTWO), 15 have Buy rating, 1 Sell and 3 Hold. Therefore 79% are positive. Take-Two Interactive Software had 68 analyst reports since July 28, 2015 according to SRatingsIntel. On Friday, September 8 the stock rating was maintained by Piper Jaffray with “Buy”. The stock has “Buy” rating by Stifel Nicolaus on Tuesday, October 31. The firm has “Buy” rating by Piper Jaffray given on Wednesday, October 11. The stock of Take-Two Interactive Software, Inc. (NASDAQ:TTWO) has “Buy” rating given on Wednesday, November 8 by Jefferies. BMO Capital Markets maintained the shares of TTWO in report on Thursday, September 7 with “Buy” rating. The rating was maintained by Piper Jaffray on Wednesday, June 7 with “Buy”. Brean Capital maintained the shares of TTWO in report on Tuesday, August 11 with “Buy” rating. The firm earned “Buy” rating on Monday, December 18 by BTIG Research. The company was maintained on Thursday, August 3 by BMO Capital Markets. Jefferies maintained it with “Buy” rating and $108.0 target in Sunday, September 10 report.

Since August 4, 2017, it had 0 insider purchases, and 4 insider sales for $7.68 million activity. Goldstein Lainie had sold 30,000 shares worth $2.63M on Friday, August 4. Sheresky Michael also sold $41,831 worth of Take-Two Interactive Software, Inc. (NASDAQ:TTWO) shares. ZELNICK STRAUSS also sold $4.39 million worth of Take-Two Interactive Software, Inc. (NASDAQ:TTWO) on Friday, August 4.

Analysts await Take-Two Interactive Software, Inc. (NASDAQ:TTWO) to report earnings on February, 6. They expect $0.84 earnings per share, up 18.31% or $0.13 from last year’s $0.71 per share. TTWO’s profit will be $95.80 million for 34.91 P/E if the $0.84 EPS becomes a reality. After $0.76 actual earnings per share reported by Take-Two Interactive Software, Inc. for the previous quarter, Wall Street now forecasts 10.53% EPS growth.

Emerald Mutual Fund Advisers Trust, which manages about $1.06B and $2.40 billion US Long portfolio, upped its stake in Portola Pharmaceuticals Inc (NASDAQ:PTLA) by 12,197 shares to 374,908 shares, valued at $20.26 million in 2017Q3, according to the filing. It also increased its holding in Box Inc by 224,210 shares in the quarter, for a total of 721,990 shares, and has risen its stake in Planet Fitness Inc.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Leave a Reply

Your email address will not be published. Required fields are marked *